No headlines found.
Xtant Medical Reports First Quarter 2026 Financial Results
PRNewswire (Wed, 13-May 7:00 AM ET)
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
PRNewswire (Thu, 7-May 8:00 AM ET)
Xtant Medical Expands Trivium Portfolio with the Commercial Launch of Trivium Shaped
PRNewswire (Wed, 6-May 5:34 PM ET)
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Xtant Medical Holdings trades on the AMEX stock market under the symbol XTNT.
As of July 21, 2026, XTNT stock price declined to $0.44 with 73,314 million shares trading.
XTNT has a beta of 0.17, meaning it tends to be less sensitive to market movements. XTNT has a correlation of 0.00 to the broad based SPY ETF.
XTNT has a market cap of $62.40 million. This is considered a Micro Cap stock.
Last quarter Xtant Medical Holdings reported $21 million in Revenue and -$.02 earnings per share. This beat revenue expectation by $1 million and met earnings estimates .
In the last 3 years, XTNT traded as high as $1.45 and as low as $.33.
The top ETF exchange traded funds that XTNT belongs to (by Net Assets): VTI, VXF.
XTNT has underperformed the market in the last year with a return of -29.3%, while the SPY ETF gained +20.4%. In the last 3 month period, XTNT fell short of the market, returning -11.0%, while SPY returned +5.9%. However, in the most recent 2 weeks XTNT has outperformed the stock market by returning +6.7%, while SPY returned -0.4%.
XTNT support price is $.42 and resistance is $.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XTNT shares will trade within this expected range on the day.